glycosidase inhibitors (Cornell)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameglycosidase inhibitors (Cornell)
Drug Alias Namemonosaccharide analog-based glycosidase inhibitors (Cornell)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycoside hydrolases inhibitors
TargetsGlycoside hydrolases
Therapy Area/IndicationsDiabetes MellitusNeoplasmsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCornell University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCornell University
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusNeoplasmsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A